HUMIRA® received approval for the treatment of rheumatoid arthritis in Japan
[ 2008/04/16 | Eisai Co., Ltd. | Pharmaceuticals | Tokyo | TSE1(PRIME) ]

The Company's Official Page
http://www.eisai.co.jp/enews/enews200820.html
Back To Previous Page
Dear User,
JPubb program could not collect the texts of this press-release from the official page, which perhaps mainly comprises tables, charts or images. Please refer to the official page indicated above. -- by JPubb

Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

more
    この内容でのリリース掲載はまだ無いか、集計されておりません。

more

Most Popular: Pharmaceuticals

1. Kaken Pharmaceutical and Taiyo Yakuhin E...
Kaken Pharmaceutical Co.,Ltd. 2004/04/27
2. GlaxoSmithKline and Kaken Pharmaceutical...
Kaken Pharmaceutical Co.,Ltd. 2002/12/16
3. KAKEN PHARMACEUTICAL CO., LTD. and the I...
Kaken Pharmaceutical Co.,Ltd. 2000/12/14
4. ALOXI® (PALONOSETRON HCL) INJECTION...
Eisai Co., Ltd. 2008/07/09
5. Status of the E2007 (perampanel) Develop...
Eisai Co., Ltd. 2008/04/11

Latest News: Eisai Co., Ltd.


more

Most Popular: Eisai Co., Ltd.

1. E7389 Demonstrated Anti-tumor Activity i...
2008/05/16
2. HUMIRA® received approval for the t...
2008/04/16

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

■Home

■Terms & Conditions

■Twitter ■Facebook

■About Us